Senior Director, Cell Therapy WW Medical Affairs, Multiple Myeloma Princeton Pike - NJ + 1 more R1604746

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

At BMS, we are committed to the advancement of science with the drive to improve every day for the benefit of patients. To accelerate our position as leaders in cell therapy and serve patients around the world, we are committed to being at the forefront of change.
Reporting to the Executive Director, Cell Therapy Multiple Myeloma, the Senior Director, WW Medical, Multiple Myeloma Cell Therapy will represent WW Medical Affairs as a therapeutic area expert and provide strategic scientific leadership for arlo-cel, our GPRC5D CAR T currently in clinical development in multiple myeloma. This individual will be accountable for driving global launch readiness, including external communications and market shaping, internal readiness, and strategic partnership on launch activities across the matrix.

The role carries forward-looking responsibility across the broader MM Cell Therapy portfolio, including lifecycle management priorities and evidence generation strategy.
The role requires depth of scientific expertise, credibility with external thought leaders, and the leadership composure to operate effectively at the intersection of WW commercialization, local Medical Affairs, and global Clinical Development. This is a high-visibility, high-impact role at a pivotal moment in the evolution of BMS's Cell Therapy franchise, demanding an individual who can balance strategic vision with flawless operational execution in a complex, matrixed environment.

• Lead WW Medical Affairs strategy for arlo-cel, driving global launch readiness across external communications, market shaping, and internal readiness activities
• Lead cross-functional initiatives related to arlo-cel, integrating strategies across the MM portfolio where necessary
• Collaborate with local Medical Affairs teams to align on launch strategy and tactics, ensuring cohesive, market-ready action plans globally
• Drive cross-asset collaboration and knowledge sharing, fostering a unified BMS presence in multiple myeloma, including partnerships across Cell Therapy and Oncology
• Establish and cultivate relationships with key thought leaders and KOLs at major academic centers; engage cooperative groups, steering committees, and advisory boards to generate insights and shape the evolving treatment paradigm

• Provide strategic input to guide publication planning and execution; serve as a key reviewer on abstracts, presentations, and publications
• Develop and implement congress strategies to achieve impactful scientific presence and engagement at major meetings including COMy, EHA, and IMS
• Provide strategic input into BMS-sponsored symposia and independent medical education events to enhance scientific dialogue
• Refine the Integrated Evidence Plan (IEP) to ensure alignment with cross-functional goals; provide strategic input for evidence generation projects, including expert review and recommendations for new ISR and CRC trials as well as HEOR analyses
• Represent arlo-cel as a leading member of the WW MM Asset Indication Medical Strategy (AIMS) team to ensure the global Medical Affairs strategy and deliverables are aligned across key medical functions and markets
• Conduct comprehensive reviews of publications and update key launchpad assets, including slide decks, training sessions, and Q&A materials
• Ensure scientific excellence in medical education and effective data exchange

• Offer medical insights to guide clinical development…